Paul L. Hallenbeck - Concepedia

Concepedia

Author

Paul L. Hallenbeck

Research Institute for Genetic and Human Therapy

Also Known As

P Hallenbeck, P L Hallenbeck, P. Hallenbeck, P. L. Hallenbeck, P.L. Hallenbeck, Paul Hallenbeck, Paul L Hallenbeck, Paul L. Hallenbeck

53

Publications

3.2K

Citations

25

H-Index

60

Concepts

All Affiliations

Research Institute for Genetic and Human Therapy Novartis (United States)Scripps Research Institute National Institutes of Health Baylor College of Medicine

PL

About

Paul L. Hallenbeck is an author at Research Institute for Genetic and Human Therapy specializing in medicine, gene expression, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	2K
2	Natural Sciences	4	4	305
3	Biochemistry	3	3	189
4	Biology	3	3	287
5	Engineering	2	2	126

Paul L. Hallenbeck

×

25

Publications

3.2K

Citations

25

H-Index

	Year	Citations
H-2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. Michael S. Marks, Paul L. Hallenbeck, Toshi Nagata, The EMBO Journal Transcriptional RegulationSignal TransductionMolecular PhysiologyRxr BetaCell Regulation	1992	474
Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus Laura M. Hales, Nick J. Knowles, P. Seshidar Reddy, Journal of General Virology	2008	374
A Novel Tumor-Specific Replication-Restricted Adenoviral Vector for Gene Therapy of Hepatocellular Carcinoma Paul L. Hallenbeck, Doug Golightly, David A. Stewart, Human Gene Therapy ImmunologyPathologyCancer DeathTumor MassCancer Biology	1999	283
Seneca Valley Virus, a Systemically Deliverable Oncolytic Picornavirus, and the Treatment of Neuroendocrine Cancers P. Seshidhar Reddy, Kevin D. Burroughs, Laura M. Hales, JNCI Journal of the National Cancer Institute	2007	250
Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Shuichi Kaneko, Paul L. Hallenbeck, Takenori Kotani, PubMed Synthetic VirologyImmunologyPathologyTumor BiologyAdenovirus-mediated Gene Therapy	1995	177
Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and heterologous promoter. Antonella Farsetti, Béatrice Desvergne, Paul L. Hallenbeck, Journal of Biological Chemistry Mbp PromoterGeneticsHeterologous PromoterTranscriptional RegulationNative Promoter	1992	173
Phase I Clinical Study of Seneca Valley Virus (SVV-001),a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features Charles M. Rudin, John T. Poirier, Neil Senzer, Clinical Cancer Research	2011	153
Structure of Seneca Valley Virus-001: An Oncolytic Picornavirus Representing a New Genus Sangita Venkataraman, Seshidhar P. Reddy, Jackie Loo, Structure BiologyVirus StructureViral EvolutionPathogenesisPathology	2008	145
DNA binding and heteromerization of the Drosophila transcription factor chorion factor 1/ultraspiracle. Anastasia M. Khoury christianson, D L King, Eudoxia Hatzivassiliou, Proceedings of the National Academy of Sciences GeneticsGenomic MechanismMolecular BiologyMolecular GeneticsEpigenetics	1992	127
An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy. John Jakubczak, Patricia C. Ryan, M Gorziglia, PubMed PathologyCancer BiologyTumor BiologyRetinoblastoma Tumor SuppressorCancer-associated Virus	2003	99

Page 1